TAKEDA PHARMACEUTIC-SP ADR (TAK) Stock Institutional Trading Activity


TAKEDA PHARMACEUTIC-SP ADR (TAK) position changes reported by tracked institutional filers across multiple SEC 13F reporting periods. Based on recent SEC 13F filings (Q4 2025), investors with some of the largest reported share count changes include Renaissance Technologies LLC, Hancock Classic Value, Sequoia Financial Advisors, Causeway Capital Management, and ARK Invest. Explore insights into buying and selling patterns, position changes, and investment conviction levels to understand institutional trading behavior and market dynamics.

Explore more:

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q1 2023Sequoia Financial AdvisorsBuy1,69221,189$349,195
Q1 2023Causeway Capital ManagementSell-200,6761,129,366$18,611,952
Q4 2022Renaissance Technologies LLCBuy15,3002,864,400$44,685
Q4 2022Sequoia Financial AdvisorsBuy7,22019,497$304,153
Q4 2022Causeway Capital ManagementSell-100,6631,330,042$20,748,648
Q3 2022Sequoia Financial AdvisorsBuy2,15012,277$159
Q3 2022Causeway Capital ManagementSell-76,1181,430,705$18,556
Q3 2022Renaissance Technologies LLCBuy20,8002,849,100$36,953
Q2 2022Sequoia Financial AdvisorsSell-75910,127$142
Q2 2022Causeway Capital ManagementSell-94,2231,506,823$21,156
Q2 2022Renaissance Technologies LLCBuy835,1002,828,300$39,709
Q1 2022Sequoia Financial AdvisorsBuy10,88610,886$156
Q1 2022Causeway Capital ManagementBuy91,8971,601,046$22,927
Q1 2022Renaissance Technologies LLCBuy274,4001,993,200$28,543
Q4 2021ARK InvestSell-5,639,2717,862,379$107,164
Q4 2021Causeway Capital ManagementSell-397,8491,509,149$20,570
Q4 2021Renaissance Technologies LLCSell-438,1001,718,800$23,427
Q3 2021ARK InvestSell-1,991,34713,501,650$221,157
Q3 2021Causeway Capital ManagementSell-124,2661,906,998$31,237
Q3 2021Renaissance Technologies LLCSell-140,1002,156,900$35,330
Q2 2021ARK InvestSell-3,224,14715,492,997$260,747
Q2 2021Causeway Capital ManagementBuy357,8092,031,264$34,186
Q2 2021Renaissance Technologies LLCSell-1,137,6002,297,000$38,659
Q1 2021ARK InvestBuy10,098,97918,717,144$341,775
Q1 2021Causeway Capital ManagementBuy129,2841,673,455$30,557
Q1 2021Renaissance Technologies LLCSell-2,144,1003,434,600$62,716
Q4 2020ARK InvestBuy7,461,8688,618,165$156,851
Q4 2020Causeway Capital ManagementBuy65,6471,544,171$28,104
Q4 2020Renaissance Technologies LLCSell-158,0075,578,700$101,532
Q3 2020ARK InvestBuy1,156,2971,156,297$20,628

Frequently asked questions about TAK activity

  • Which institutional owners are buying TAK?

    Institutional owners buying TAK include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in TAK activity?

    "Buy" means an investor increased their reported position in TAK compared to the prior reporting period. This reflects growing exposure to TAKEDA PHARMACEUTIC-SP ADR (TAK) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in TAK increasing?

    Institutional interest in TAK can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.